INNOVATIONS IN VISION: Nanotech, Nearsightedness and Neuro-Ophthalmology ImagingMonday, Nov. 16, 8:00 a.m. PST at AAO 2015
Who/What: Newswise — Listen to the latest breakthroughs in eye care from scientists presenting at the world’s largest ophthalmology conference, AAO 2015. Three ophthalmology researchers will discuss their cutting-edge work on topics ranging from using nanoparticles to treat blinding retinal diseases to eye drops that could slow nearsightedness in children. Please note embargo times below.
Topics and speakers include:
•Could eye drops help tame the global “myopia epidemic”?Donald Tan, M.D., Ph.D., Singapore Eye Research Institute, National University of Singapore Nearsightedness has dramatically increased worldwide. About 40 percent of people in the United States and close to 90 percent in parts of Asia are myopic. One emerging weapon in the fight against the “myopia epidemic” is medicated eye drops. Dr. Tan’s research shows a new lower-dose formulation of atropine safely slowed down the progression of myopia in children in a five-year clinical trial, offering a possible solution to this growing global health issue. Information presented is embargoed until Dr. Tan presents Five-Year Clinical Trial on Atropine for the Treatment of Myopia during SYM32 at the time and date listed below. Embargoed until 3:16 p.m. PST, Nov. 16
•Teeny, tiny particles fight big, blinding eye diseases Emmanuel Chang, M.D., Ph.D., Retina & Vitreous of TexasNanotechnology applies principles in biology, chemistry and physics to real-world applications on the molecular scale. Dr. Chang will discuss these potential applications may be applied to retinal diseases, including concepts and approaches to modifying or enhancing existing therapeutic tools. Topics include evaluating hydrocarbon nano-clusters as a free radical scavenger agent and constructing nanophotoreceptors. Content embargoed until Dr. Chang presents Nanotechnology in Retinal Disease during SYM22 at the time and date listed below.Embargoed until 10:47 a.m. PST, Nov. 16
•Scanning saves sight – new ways to look at the link between the eyes and brainRandy H. Kardon, M.D., Ph.D., University of Iowa Carver College of MedicineOptical coherence tomography (OCT) is a non-invasive imaging test that uses light waves to take pictures of the retina, the light-sensitive tissue lining the back of the eye. Dr. Kardon will use case studies to demonstrate how innovations in OCT are improving the diagnosis and monitoring of patients with vision loss from neuro-ophthalmologic problems located in the retina, optic nerve or visual pathways in the brain. Content embargoed until Dr. Kardon presents The Evolving Role of OCT in Neuro-Ophthalmology during SYM32 at the time and date listed below. Embargoed until 3:56 p.m. PST, Nov. 16
A question and answer session will follow the researchers’ presentations.
Where/When: Sands Expo, 201 Sands Ave., Las Vegas, NV 89169Press briefing room, 310Monday, Nov. 16, 8:00 – 8:45a.m. PST
Please RSVP: By 5 p.m. PST, Friday, Nov. 13, by emailing [email protected] or calling our media line at 415-561-8534 until Nov. 11, or the AAO 2015 Newsroom at 702-691-8621 Nov. 12 and after. Advance press registration required for AAO 2015 entry. Please register by Nov. 13 at http://www.aao.org/newsroom/annual-meeting-for-media. Background:For more information about the American Academy of Ophthalmology – the world’s largest association of eye physicians and surgeons – and its 119th annual meeting, read the meeting highlights release at: http://www.aao.org/newsroom/news-releases/detail/aao-2015-showcases-latest-in-vision-research-innov
RSS